- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Adjunctive Brain Volume Quantification Tool for MRI Gets FDA Clearance
Providing automated brain volume calculations based on MRI images, NeuroShield’s artificial intelligence (AI)-powered technology may help facilitate treatment for neurodegenerative conditions ranging from Alzheimer’s disease to epilepsy.
A brain volume quantification tool that may provide early insights on neurodegenerative conditions based on magnetic resonance imaging (MRI) assessment, the artificial intelligence (AI)-enabled NeuroShield has garnered 510(k) clearance from the Food and Drug Administration (FDA).
Currently being utilized in over 200 facilities across the world, NeuroShield offers automated brain volume assessment based upon 3D MRI scans, according to InMed.AI (InMed Prognostics), the developer of NeuroShield.
The company noted that the brain segmentation analysis provided with NeuroShield has demonstrated high accuracy rates across different clinical subgroups and magnetic strengths in a trial of 280 subjects. InMed.AI noted that NeuroShield may aid in the early detection of brain atrophy, possibly facilitating timely intervention for those at risk of dementia, Alzheimer’s disease and other neurodegenerative conditions.
“We believe that investing in our collective human future and that technology is a great lever to move towards precision health to extend quality of life,” added Latha Poonamallee, Ph.D., the founder and CEO of InMed Prognostics.
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.
